US Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers US Diabetes Devices Companies and It is Segmented by Management Devices (insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, And Jet Injectors) and Monitoring Devices (self-Monitoring Blood Glucose and Continuous Glucose Monitoring). The Report Offers the Value (in USD) for the Above Segments.

US Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

US Diabetes Devices Market Size

View Global Report
United States Diabetes Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 26.74 Billion
Market Size (2030) USD 36.24 Billion
CAGR (2025 - 2030) 6.27 %

Major Players

United States Diabetes Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of United States Diabetes Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

US Diabetes Devices Market Analysis

The United States Diabetes Devices Market size is estimated at USD 26.74 billion in 2025, and is expected to reach USD 36.24 billion by 2030, at a CAGR of 6.27% during the forecast period (2025-2030).

Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and, thus, incur more healthcare expenses compared to non-diabetic people. People with diabetes face a higher chance of experiencing serious complications from COVID-19. Doctors and the government are asking diabetes patients to check their glucose levels continuously. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus. 

According to the AACE (American Association of Clinical Endocrinologists), recent studies have shown that of those hospitalized for severe disease, 22.2-26.9% reported living with diabetes. Diabetes and high glucose levels are associated with increased complications, respiratory failure, and mortality in hospitalized patients with coronavirus.

As of the most recent update in January 2022, diabetes remains a prominent health issue in the United States, impacting a considerable number of individuals. Approximately 34.2 million people, which accounts for 10.5% of the population, are living with diabetes. This figure encompasses both diagnosed and undiagnosed cases.

The majority of diabetes cases in the United States are classified as type 2 diabetes, making up around 90-95% of all diagnosed cases. Type 2 diabetes is closely associated with lifestyle factors such as obesity, physical inactivity, and poor dietary habits.

Although less prevalent, type 1 diabetes still affects a significant number of individuals, particularly children and young adults. It is estimated that approximately 1.6 million Americans have type 1 diabetes.

Thus due to increasing diabetes population in united states is driving the market in projected time frame.

US Diabetes Devices Industry Overview

The United States diabetes care devices market is semi-consolidated, with few significant and generic players. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market. There have been constant innovations driven by manufacturers such as Abbott and Medtronic, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.

US Diabetes Devices Market Leaders

  1. Abbott

  2. Dexcom

  3. Becton Dickinson

  4. Medtronic

  5. F. Hoffmann-La Roche AG

  6. *Disclaimer: Major Players sorted in no particular order
United States Diabetes Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

US Diabetes Devices Market News

  • August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin.
  • March 2022: Dexcom released G7 first in the U.K. and was expected to expand the launch across Europe throughout 2022. Meanwhile, the CGM system currently is under review by the Food and Drug Administration for an eventual U.S. release.

US Diabetes Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Monitoring Devices
    • 5.1.1 Self-monitoring Blood Glucose
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Blood Glucose Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables
  • 5.2 Management Devices
    • 5.2.1 Insulin Pump
    • 5.2.1.1 Insulin Pump Device
    • 5.2.1.2 Insulin Pump Reservoir
    • 5.2.1.3 Infusion Set
    • 5.2.2 Insulin Syringes
    • 5.2.3 Cartridges in Reusable pens
    • 5.2.4 Insulin Disposable Pens
    • 5.2.5 Jet Injectors

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Becton and Dickenson
    • 7.1.2 Medtronic
    • 7.1.3 F. Hoffmann-La Roche AG
    • 7.1.4 Insulet Corporation
    • 7.1.5 Abbott
    • 7.1.6 Dexcom
    • 7.1.7 Tandem
    • 7.1.8 Johnson & Johnson
    • 7.1.9 Ypsomed Holding
    • 7.1.10 Novo Nordisk
    • 7.1.11 Sanofi
    • 7.1.12 Eli Lilly and Company
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott
    • 7.2.1.2 F. Hoffmann-La Roche AG
    • 7.2.1.3 LifeScan
    • 7.2.1.4 Other Self-monitoring Blood Glucose Devices
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom
    • 7.2.2.2 Medtronic
    • 7.2.2.3 Abbott
    • 7.2.2.4 Other Continuous Glucose Monitoring Devices
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Omnipod
    • 7.2.3.2 Novo Nordisk
    • 7.2.3.3 Johnson & Johnson
    • 7.2.3.4 Other Insulin Devices

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

US Diabetes Devices Industry Segmentation

Patients with diabetes can monitor and control their blood glucose levels with the aid of diabetes devices. Diabetes patients' health can be dramatically improved by using diabetes devices. The United States diabetes device market is segmented into management devices and monitoring devices. The report offers the value (in USD) and volume (in units) for the above segments.

Monitoring Devices Self-monitoring Blood Glucose Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables
Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable pens
Insulin Disposable Pens
Jet Injectors
Need A Different Region or Segment?
Customize Now

US Diabetes Devices Market Research FAQs

How big is the United States Diabetes Devices Market?

The United States Diabetes Devices Market size is expected to reach USD 26.74 billion in 2025 and grow at a CAGR of 6.27% to reach USD 36.24 billion by 2030.

What is the current United States Diabetes Devices Market size?

In 2025, the United States Diabetes Devices Market size is expected to reach USD 26.74 billion.

Who are the key players in United States Diabetes Devices Market?

Abbott, Dexcom, Becton Dickinson, Medtronic and F. Hoffmann-La Roche AG are the major companies operating in the United States Diabetes Devices Market.

What years does this United States Diabetes Devices Market cover, and what was the market size in 2024?

In 2024, the United States Diabetes Devices Market size was estimated at USD 25.06 billion. The report covers the United States Diabetes Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United States Diabetes Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

US Diabetes Devices Industry Report

Statistics for the 2025 United States Diabetes Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United States Diabetes Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.